Johns Hopkins HIV Guide
Itraconazole
Itraconazole is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis (oral capsule).
- Pulmonary and extrapulmonary blastomycosis in immunocompromised and non immunocompromised pts (oral capsule).
- Onychomycosis (oral capsule).
- Oropharyngeal and esophageal candidiasis (oral liquid)
- Neutropenic fever in pts with a suspected fungal infection (oral liquid).
- Aspergillosis treatment in pts intolerant of or refractory to amphotericin B therapy (oral capsule, no longer preferred see voriconazole).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Coccidioidomycosis
- Cryptococcosis
- Penicilliosis
- Sporotrichosis
- Candida vaginitis
- Fluconazole-resistant esophageal candidiasis
- Prophylaxis of invasive fungal infections, susceptible hosts (prolonged neutropenia, GVH)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
INDICATIONS
FDA
FDA
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis (oral capsule).
- Pulmonary and extrapulmonary blastomycosis in immunocompromised and non immunocompromised pts (oral capsule).
- Onychomycosis (oral capsule).
- Oropharyngeal and esophageal candidiasis (oral liquid)
- Neutropenic fever in pts with a suspected fungal infection (oral liquid).
- Aspergillosis treatment in pts intolerant of or refractory to amphotericin B therapy (oral capsule, no longer preferred see voriconazole).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Coccidioidomycosis
- Cryptococcosis
- Penicilliosis
- Sporotrichosis
- Candida vaginitis
- Fluconazole-resistant esophageal candidiasis
- Prophylaxis of invasive fungal infections, susceptible hosts (prolonged neutropenia, GVH)
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: December 22, 2011
Citation
Pham, Paul A, and John G Bartlett. "Itraconazole." Johns Hopkins HIV Guide, 2011. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole.
Pham PA, Bartlett JG. Itraconazole. Johns Hopkins HIV Guide. 2011. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole. Accessed June 4, 2020.
Pham, P. A., & Bartlett, J. G. (2011). Itraconazole. In Johns Hopkins HIV Guide Retrieved June 04, 2020, from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole
Pham PA, Bartlett JG. Itraconazole [Internet]. In: Johns Hopkins HIV Guide. ; 2011. [cited 2020 June 04]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Itraconazole
ID - 545112
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
Y1 - 2011/12/22/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
